Number of patients | 218 | C3 (mean ± SD) (g/l) | 0.45 ± 0.23 |
---|---|---|---|
Gender (male/female) | 33/185 | Anti-nuclear antibody (ANA) (+) No.(%) | 215 (98.6) |
Age (mean ± SD) (years) | 32.5 ± 11.3 | Anti-double stranded DNA antibody (ds-DNA) (+) No.(%) | 153 (70.6) |
Follow-up time (median, range) (months) | 41 (1,360) | Anti-SSA antibody (+) No.(%) | 102 (46.8) |
Fever (non-infectious) No.(%) | 69 31.7) | Anti-SSB antibody (+) No.(%) | 25 (11.5) |
Malar rash No.(%) | 118 (54.1) | Anti-Smith antibody(Sm) (+) No.(%) | 53 (24.3) |
Photosensitivity No.(%) | 47 (21.6) | Anti-ribonucleoprotein (RNP) antibody (+) No.(%) | 66 (30.3) |
Oral ulcer No.(%) | 64 (29.4) | Anti- cardiolipin antibody (+) No.(%) | 16 (7.3) |
Alopecia No.(%) | 68 (31.2) | SLEDAI (mean ± s.d.) | 17.6 ± 5.8 |
Arthralgia No.(%) | 115 (52.8) | Activity indices (AI) score (median, range) | 8 (0,19) |
Serositis No.(%) | 34 (15.6) | Endocapillary hypercellualrity (median, range) | 3 (0,-3) |
Neurologic disorder No.(%) | 14 (6.4) | Cellular crescents (median, range) | 0 (0,6) |
Anemia No.(%) | 147 (67.4) | Karyorrhexis/fibrinoid necrosis (median, range) | 0 (0,6) |
Leukocytopenia No.(%) | 102 (46.8) | Subendothelial hyaline deposits (median, range) | 1 (0,3) |
Thrombocytopenia No.(%) | 64 (29.4) | Interstitial inflammatory cell infiltration (median, range) | 1 (0,3) |
Hematuria No.(%) | 168 (77.1) | Glomerular leukocyte infiltration (median, range) | 1 (0,12) |
Leukocyturia (non-infection) No.(%) | 118 (54.1) | Chronicity indices (CI) score (median, range) | 2 (0,10) |
Acute renal failure No.(%) | 39 (17.9) | Glomerular sclerosis (median, range) | 0 (0,3) |
Hemoglobin (mean ± SD) (g/l) | 100.92 ± 26.36 | Fibrous crescents (median, range) | 0 (0,3) |
Urine protein (median, range) (g/24 hours) | 4.36 (0–17) | Tubular atrophy (median, range) | 1 (0,3) |
Serum creatinine (median, range) (μmol/l) | 82.0 (37,1000) | Interstitial fibrosis (median, range) | 1 (0,3) |